the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

KPKM implements programme to reduce dependency on imported onions

KUALA LUMPUR: The onion cultivation programme, which will be implemented in phases starting this year until 2030, is expected to reduce the country’s onion imports by 30 per cent, said Agriculture and Food Security Minister Datuk Seri Mohamad Sabu.

According to him, the programme would be implemented in two phases, namely the pre-commercial phase from this year to next year, followed by the commercial phase from 2026 to 2030.

He explained that the pre-commercial phase aims to assess the viability of small red onion cultivation in Malaysia, with the Malaysian Agricultural Research and Development Institute (MARDI) supplying 70 tonnes of small onion seeds and 230 kilogramme (kg) of small red onion seeds.

Mohamad said during the pre-commercial phase, an onion cultivation area spanning 100 hectares will be established, with an estimated production yield of five tonnes per hectare.

“Onion cultivation can be done twice each year. Onion production (during this pre-commercial phase) is anticipated to reach 1,000 tonnes,” he said during the question and answer session at the Dewan Rakyat today.

He said this in reply to a question from Datuk Idris Ahmad (PN-Bagan Serai) regarding the Ministry of Agriculture and Food Security’s (KPKM) efforts to reduce onion imports by 30 per cent.

Elaborating, Mohamad said the commercial phase of the programme would involve the development of a 1,347-hectare area, with an expected onion yield of 14,470 tonnes.

He added that the programme would only involve the cultivation of small red onions, as MARDI has yet to discover suitable varieties of onions and garlic for planting in Malaysia. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings